Jun Wada

MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury

Kenji Tsuji, S. Kitamura, Kazuhiko Fukushima, 2023, Diagnostics.

A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)

Y. Hirota, T. Urakami, Junta Imai, 2024, Diabetes therapy : research, treatment and education of diabetes and related disorders.

NDUFS4 regulates cristae remodeling in diabetic kidney disease

G. Fan, I. Serysheva, Collene R. Jeter, 2024, Nature communications.

Role of Semaphorin 3A in Kidney Development and Diseases

Kenji Tsuji, S. Kitamura, Kazuhiko Fukushima, 2023, Diagnostics.

Renal outcomes with sodium‐glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases

Maki Gouda, A. Miyawaki, Hiroaki Iijima, 2024, Diabetes, obesity & metabolism.

Inhibition of Amino Acids Influx into Proximal Tubular Cells Improves Lysosome Function in Diabetes

A. Nakatsuka, K. Mise, Ryosuke Sugawara, 2023, Kidney360.